Clinical Trials for EpiDestiny

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: EpiDestiny

Clinical Trials (2)

NCT07006025
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
PHASE1Recruiting
20 participants
Started: Jun 3, 2025 · Completed: Mar 30, 2027
1 condition1 sponsor1 location
NCT04055818
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
PHASE1Recruiting
20 participants
Started: Jan 24, 2020 · Completed: Apr 30, 2027
1 condition3 sponsors1 location